Vyvanse and Tachypnea - a phase IV clinical study of FDA data
Summary:
Tachypnea is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Ventolin, and have Asthma.
The phase IV clinical study analyzes which people have Tachypnea when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,870 Vyvanse users. Check the latest studies of Vyvanse.
What is Tachypnea?
Tachypnea is found to be associated with 1,054 drugs and 1,953 conditions by eHealthMe. Check the latest studies of Tachypnea.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
28,083 people reported to have side effects when taking Vyvanse.
Among them, 16 people (0.06%) have Tachypnea.

Among these 16 people:
How long have people been on Vyvanse when they have Tachypnea? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Tachypnea when taking Vyvanse? *
- female: 92.31 %
- male: 7.69 %
What is the age of people who have Tachypnea when taking Vyvanse? *
- 0-1: 0.0 %
- 2-9: 23.08 %
- 10-19: 15.38 %
- 20-29: 7.69 %
- 30-39: 30.77 %
- 40-49: 0.0 %
- 50-59: 23.08 %
- 60+: 0.0 %
What are other drugs people take besides Vyvanse? *
- Ventolin: 7 people, 43.75%
- Abilify: 5 people, 31.25%
- Omnaris: 5 people, 31.25%
- Singulair: 5 people, 31.25%
- Advair Hfa: 5 people, 31.25%
- Vitamin C: 5 people, 31.25%
- Breo Ellipta: 5 people, 31.25%
- Clonazepam: 5 people, 31.25%
- Toviaz: 5 people, 31.25%
- Pantoprazole Sodium: 5 people, 31.25%
What are other side effects people have besides Tachypnea? *
- High Blood Pressure: 13 people, 81.25%
- Dyspnea (difficult or laboured breathing): 9 people, 56.25%
- Heart Rate Increased: 9 people, 56.25%
- Asthma: 8 people, 50.00%
- Malaise (a feeling of general discomfort or uneasiness): 7 people, 43.75%
- Back Pain: 7 people, 43.75%
- Headache (pain in head): 7 people, 43.75%
- Arrhythmias (irregular heartbeat): 6 people, 37.50%
- Chest Pain: 6 people, 37.50%
- Fever: 6 people, 37.50%
What are the existing conditions these people have? *
- Type 2 Diabetes: 5 people, 31.25%
- Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 5 people, 31.25%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 31.25%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 31.25%
- Asthma: 5 people, 31.25%
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 12.50%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 12.50%
- Pain: 1 person, 6.25%
- Immunodeficiency Common Variable: 1 person, 6.25%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and have Tachypnea?
- Check whether Tachypnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vyvanse:
- Vyvanse (35,870 reports)
Tachypnea treatments and more:
- Tachypnea (16,675 reports)
How severe was Tachypnea and when was it recovered:
Expand to all the drugs that have ingredients of lisdexamfetamine dimesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Tachypnea:
- Tachypnea (1,054 drugs)
Browse all the conditions that are associated with Tachypnea:
- Tachypnea (1,953 conditions)
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Dexlansoprazole and Mobility Decreased for Men aged 50-59 - 2 seconds ago
- Lopurin and Adriamycin Pfs drug interactions for men aged 60+ - 4 seconds ago
- Sodium Bicarbonate and Cardiac Amyloidosis for Women aged 60+ - 9 seconds ago
- Sodium Bicarbonate and Stiff Heart Syndrome for Women aged 60+ - 9 seconds ago
- Sodium Bicarbonate and Senile Amyloidosis for Women aged 60+ - 10 seconds ago
- Sodium Bicarbonate and Secondary Cardiac Amyloidosis - Aa Type for Women aged 60+ - 10 seconds ago
- Sodium Bicarbonate and Primary Cardiac Amyloidosis - Al Type for Women aged 60+ - 11 seconds ago
- Sodium Bicarbonate and Amyloidosis - Cardiac for Women aged 60+ - 11 seconds ago
- Sodium Bicarbonate and Amyloidosis - Senile for Women aged 60+ - 11 seconds ago
- Oxaliplatin and Hepatic Cirrhosis for Men aged 50-59 - 20 seconds ago